Cargando…
Paclitaxel inhibits breast cancer metastasis via suppression of Aurora kinase-mediated cofilin-1 activity
The main problem in breast cancer treatment is the recurrence of tumor growth and metastases. Previous studies have suggested that Paclitaxel is widely used to treat various cancers. The present study analyzed the potential signaling pathway of Paclitaxel-inhibited breast cancer metastasis. It was d...
Autores principales: | Zhang, Yue, Wang, Yaoyi, Xue, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776659/ https://www.ncbi.nlm.nih.gov/pubmed/29434713 http://dx.doi.org/10.3892/etm.2017.5588 |
Ejemplares similares
-
Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
por: Skov, Natascha, et al.
Publicado: (2022) -
Role of aurora kinase B in regulating resistance to paclitaxel in breast cancer cells
por: Liu, Min, et al.
Publicado: (2022) -
Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2
por: Zhang, Yue, et al.
Publicado: (2021) -
JG6, a novel marine-derived oligosaccharide, suppresses breast cancer metastasis via binding to cofilin
por: Huang, Xun, et al.
Publicado: (2014) -
Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
por: Yang, Na, et al.
Publicado: (2019)